UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000008423 |
|---|---|
| Receipt number | R000009912 |
| Scientific Title | Single institute phase II study of neoadjuvant chemotherapy with trastuzumab and letrozole for postmenopausal ER-positive/HER2-positive breast cancers |
| Date of disclosure of the study information | 2012/07/16 |
| Last modified on | 2020/03/15 14:58:52 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2012/07/13 10:49:10 | ||
| 2 | Update | 2014/01/13 11:03:43 | TEL Last name of contact person Last name of contact person Address Address |
|
| 3 | Update | 2015/01/13 13:13:41 | Organization Organization Organization1 Tel1 Email1 |
|
| 4 | Update | 2015/07/13 09:40:30 | Key inclusion criteria |
|
| 5 | Update | 2016/07/14 08:56:33 | Name of primary person or sponsor Organization |
|
| 6 | Update | 2020/03/15 14:54:40 | Recruitment status Date of IRB Anticipated trial start date Last follow-up date |
|
| 7 | Update | 2020/03/15 14:56:21 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Address Last name of contact person Last name of contact person Zip code Address Organization Organization Address Address Tel |
|
| 8 | Update | 2020/03/15 14:58:52 | URL releasing protocol URL related to results and publications Number of participants that the trial has enrolled Results Results Results date posted Baseline Characteristics Baseline Characteristics Participant flow Participant flow Adverse events Adverse events Outcome measures Outcome measures |
